✦ LIBER ✦

Single oral dose cure of lethalP. yoeliiwith a new iron chelator in human clinical trials for iron overload

✍ Scribed by Abhai Tripathi, Hugh Rienhoff, David Sullivan

Book ID: 120686536
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 346 KB
Volume: 9
Category: Article
ISSN: 1475-2875
DOI: 10.1186/1475-2875-9-S2-P54

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of ICL670, a Once-Daily Oral

Evaluation of ICL670, a Once-Daily Oral Iron Chelator in a Phase III Clinical Trial of β-Thalassemia Patients with Transfusional Iron Overload

✍ RENZO GALANELLO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Selection of a new generation of orally

Selection of a new generation of orally active α-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload

✍ G. J. Kontoghiorghes; J. Barr; P. Nortey; L. Sheppard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 909 KB

The prospect of selecting oral a-ketohydroxypyrldine chelators Intended for clinical use in iron overload has been examined using several animal models of efficacy and toxicity. Studies using iron dextran-loaded mice labelled with 50Fe have shown that only the 1-substituted methyl, ethyl, (n)propyl,